09 – The promise of rubella vaccines and MR

in page functions

This workshop aimed to give EPI managers, national planners, civil society representatives and others a better understanding to make the case for rubella vaccine introduction

GAVI_2012_Ryan Youngblood copyF

Copyright GAVI/2012/Ryan Youngblood

In this workshop, aimed to give EPI managers, national planners, civil society representatives and others a better understanding to make the case for rubella vaccine introduction, participants walked away with concrete examples from Laos and Ghana on the steps to take to successfully introduce MR vaccine into national immunisation programmes.

The session began with an overview of the tragedy and burden rubella has not only on individuals, but for families and societies as well.

The financial impact of this burden was also presented, followed by the rationale for introduction and policy requirements.

The opportunities MR as a combined vaccine can have on measles prevention provided the back-drop for making the case to simultaneously introduce rubella and measles with a modest additional cost.

Participants learned about the programmatic introduction undertaken by Laos, including how to assess disease burden for rubella, making the case to the government for introduction, to full implementation.

From Ghana, a more in depth look at readying national introductions, provided the audience with a step by step outline to launch MR.

The workshop concluded with a presentation on GAVI support to rubella, including eligibility, application procedures and scope of support.

Overall, participants left the room with a good overview to make the case in their own countries for MR, armed with concrete examples provided by in-country experience, and finally with the knowledge on accessing support to make it happen.

70%

70% of cervical cancer cases can be prevented with human papillomavirus vaccines.

World Health Organization

More facts...

close icon

modal window here